Using hyperspectral imaging during brain surgery
A Prospective Observational Study to Evaluate the Use of an Intraoperative Hyperspectral Imaging System in Neurosurgery
This study is testing whether a special imaging technology can help surgeons see brain tumors and important structures better during surgery to improve outcomes for adults with these conditions.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 81 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | King's College London Academic / other |
| Locations | 1 site (London) |
| Trial ID | NCT05294185 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on the use of hyperspectral imaging technology during neurosurgical procedures to improve the identification of brain tumors and critical structures such as nerves and blood vessels. By enhancing the visualization of tissue perfusion and oxygenation, the study aims to assist surgeons in making more informed decisions during surgery, potentially leading to better outcomes for patients. The study will involve adult patients diagnosed with brain tumors or vascular issues who are scheduled for elective surgery at King's College NHS Foundation Trust.
Who should consider this trial
Good fit: Ideal candidates for this study are adult patients aged 18 and over who have been diagnosed with a brain tumor, arteriovenous malformation (AVM), or aneurysm and are scheduled for elective surgery.
Not a fit: Patients under 18 years of age or those who have previously undergone brain surgery may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the need for repeat surgeries by ensuring more complete tumor removal during the initial operation.
How similar studies have performed: While the use of hyperspectral imaging in surgery is a relatively novel approach, there have been preliminary studies suggesting its potential effectiveness in improving surgical outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients aged 18 years and over * Patients with a diagnosis of a brain tumour (any type), AVM or aneurysm who are scheduled for elective surgery * Patients able to provide written informed consent Exclusion Criteria: * Patients under 18 years of age * Patients who have previously had brain surgery
Where this trial is running
London
- King's College NHS Foundation Trust — London, United Kingdom (Recruiting)
Study contacts
- Principal investigator: Jonathan Shapey — King's College London
- Study coordinator: Jonathan Shapey
- Email: Jonathan.shapey@kcl.ac.uk
- Phone: 02078365454
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.